Cannabidiol (CBD), one of the main by-products of the cannabis plant, does not have marijuana’s typical psychological effects. It has been suggested that CBD has anti inflammatory effects on animal cells and that it can also be used as a calming agent for people with neurological disorders. This paper will demonstrate how CBD can be effective in treatment resistant schizophrenia (TRS).
Here is the full scientific article if you wish to download it.
Main Points Covered
A 23 year old man was brought to hospital due to aggressiveness, nonsensical thoughts and hallucinations. From day 6-35 he received CBD starting with 40 mg for 5 days with the dose being doubled every 5 days because of tolerance issues. After the dose got higher for the second time, he received 10 mg of olanzapine that was also increased up to 20mg a day. Symptoms started to improve after the first upping of the dose.
CBD was then disbanded and the symptoms worsened dramatically. During CBD treatment there were no side effects reported and the patient behaved very well. Olanzapine treatment seemed to slightly sedate the patient and a weight gain was recorded too.The patient stayed psychiatrically stable, on olanzapine treatment use after a 1-year follow-up.
The patients dose was solitary for the first 5 days and then from 6 to 35, CBD dose increased to 1280 mg a day. The 36th day saw CBD treatment discontinued and the olanzapine took over for over 15 days. The patient showed amazing improvement when CBD was administered and no side effects were reported. These effects of cannabidiol suggest that it can be used as a antipsychotic medication TRS.
Although it dosesn’t have many side effects, other than drowsiness and increase in appetite, cannabis is still under trials and studies for its potential medical use.